Tamoxifen satisfaction and usage data | Monitoring more than 2,300 patients | Drug safety information

Tamoxifen (Tamoxifen) - monitoring more than 2,300 patients

Check It Now!

Get your free interaction check for Tamoxifen by entering your medicines in the boxes below:

(You can add more medicines once you register.)

Your Details

MediGuard is not a substitute for professional medical advice, and that the use of this service is at your own risk. You will always seek the advice of a qualified health provider before making any changes to your treatment.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. MediGuard cannot and does not take into account every possible interaction or account for individual responses to medicine.

Deidentified data collected by MediGuard may be used for research purposes to improve drug safety knowledge. By registering with the MediGuard service, you are agreeing to receive information about research and medical education opportunities that may be relevant to your health and safety.

I agree to MediGuard's terms of service, privacy policy and the above conditions of use.

What does it do?

This product is used in the treatment of various breast cancers and in breast cancer prevention in high-risk women. It works by binding to estrogen receptors and providing an antiestrogenic response and thus lowering the risk of cancer.

Last text update: 2011-10-04

Last data update: 2012-01-14

Black Box Warning:
This product has a black box warning relating to increased risk of endometrial cancers and an increased risk of blood clots, including pulmonary emboli.

Usage:

Tamoxifen is most commonly used to treat the conditions below, together with the percentage of all people taking the medication for the particular condition.

Breast Cancer

100%

General Information:

7.3: Tamoxifen Average Satisfaction Score

90% of patients are at least somewhat satisfied with Tamoxifen.
15% of patients wish they were told more before they started taking Tamoxifen

MediGuard regularly polls our more than 2,300 users taking Tamoxifen (or similar drugs with the same active ingredient(s)) using the Treatment Satisfaction Questionnaire for Medications (TSQM). This feedback is continuously updated for the benefit of the MediGuard community. To request scores for specific patient subgroups, please contact research@mediguard.org.

Comments

Global Patient Feedback for Tamoxifen (Tamoxifen)

Please see our forum guidelines.